Literature DB >> 22069222

Quantitative assessment of skeletal muscle degeneration in patients with myotonic dystrophy type 1 using MRI.

Bassem Hiba1, Nathalie Richard, Luc J Hébert, Chantal Coté, Mimoun Nejjari, Christoph Vial, Françoise Bouhour, Jack Puymirat, Marc Janier.   

Abstract

PURPOSE: To identify MRI biomarkers that could be used to follow disease progression and therapeutic efficacy in one individual muscle in patients with myotonic dystrophy type 1 (DM1).
MATERIALS AND METHODS: Lower limb MRI and maximal ankle dorsiflexor strength assessment, using a hand-held dynamometer, were performed in 19 DM1 patients and 6 control subjects. The volume of residual muscle tissue of Tibialis Anterior (TA) muscle was chosen as an index for muscle atrophy, and the T2-relaxation-time of the residual muscle tissue was measured to evaluate edema-like lesions. The fat-to-water ratio was assessed using three-point Dixon images to quantify fat infiltration in the entire muscle.
RESULTS: The intra-observer variability of MRI indices (∼5.2% for the residual muscle tissue volume and 2.5% for the fat-to-water ratio) was lower than that of the dorsiflexor torque measurement (∼11.5%). A high correlation (r = 0.91) was found between maximal ankle dorsiflexor strength and residual TA muscle tissue volume in DM1 patients. Increases in the fat-to-water ratio and T2-relaxation-time were associated with a decrease in maximal ankle dorsiflexor strength.
CONCLUSION: MRI appears as a noninvasive method which can be used to follow disease progression and therapeutic efficacy.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22069222     DOI: 10.1002/jmri.22849

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  22 in total

Review 1.  Quantitative proton MR techniques for measuring fat.

Authors:  H H Hu; H E Kan
Journal:  NMR Biomed       Date:  2013-10-03       Impact factor: 4.044

2.  Electromechanical delays during a fatiguing exercise and recovery in patients with myotonic dystrophy type 1.

Authors:  Fabio Esposito; Emiliano Cè; Susanna Rampichini; Elena Monti; Eloisa Limonta; Barbara Fossati; Giovanni Meola
Journal:  Eur J Appl Physiol       Date:  2017-02-14       Impact factor: 3.078

Review 3.  Inclusion body myositis.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2014-06-06       Impact factor: 3.806

4.  Test-retest reliability of automated whole body and compartmental muscle volume measurements on a wide bore 3T MR system.

Authors:  Marianna S Thomas; David Newman; Olof Dahlqvist Leinhard; Bahman Kasmai; Richard Greenwood; Paul N Malcolm; Anette Karlsson; Johannes Rosander; Magnus Borga; Andoni P Toms
Journal:  Eur Radiol       Date:  2014-05-29       Impact factor: 5.315

5.  Myotonic dystrophy type 1 alters muscle twitch properties, spinal reflexes, and perturbation-induced trans-cortical reflexes.

Authors:  Richard K Shields; Jinhyun Lee; Aaron Buelow; Michael Petrie; Shauna Dudley-Javoroski; Stephen Cross; Laurie Gutmann; Peggy C Nopoulos
Journal:  Muscle Nerve       Date:  2019-12-06       Impact factor: 3.217

6.  Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies.

Authors:  Stojan Peric; Ruzica Maksimovic; Bojan Banko; Milica Durdic; Bogdan Bjelica; Ivo Bozovic; Yunus Balcik; Jovan Pesovic; Dusanka Savic-Pavicevic; Vidosava Rakocevic-Stojanovic
Journal:  J Neurol       Date:  2017-07-29       Impact factor: 4.849

Review 7.  Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.

Authors:  Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets
Journal:  J Neuromuscul Dis       Date:  2016-03-03

8.  Fat fraction mapping using magnetic resonance imaging: insight into pathophysiology.

Authors:  Timothy Jp Bray; Manil D Chouhan; Shonit Punwani; Alan Bainbridge; Margaret A Hall-Craggs
Journal:  Br J Radiol       Date:  2017-11-21       Impact factor: 3.039

9.  Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle.

Authors:  William T Triplett; Celine Baligand; Sean C Forbes; Rebecca J Willcocks; Donovan J Lott; Soren DeVos; Jim Pollaro; William D Rooney; H Lee Sweeney; Carsten G Bönnemann; Dah-Jyuu Wang; Krista Vandenborne; Glenn A Walter
Journal:  Magn Reson Med       Date:  2013-09-04       Impact factor: 4.668

Review 10.  Myotonic dystrophy: is a narrow focus obscuring the rest of the field?

Authors:  Mani S Mahadevan
Journal:  Curr Opin Neurol       Date:  2012-10       Impact factor: 5.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.